Cyclacel Pharmaceuticals (CYCCP) Short Interest Ratio & Short Volume

Short interest is the volume of Cyclacel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 100 shares of CYCCP short. Learn More on Cyclacel Pharmaceuticals' current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.96 billion), Palo Alto Networks, Inc. ($4.37 billion), Lucid Group, Inc. ($2.87 billion), Moderna, Inc. ($2.70 billion), Rivian Automotive, Inc. ($2.31 billion), Wayfair Inc. ($2.29 billion), Snap Inc. ($2.23 billion), Datadog, Inc. ($2.21 billion), Live Nation Entertainment, Inc. ($1.96 billion), and Zoom Video Communications, Inc. ($1.89 billion). View all of the most shorted stocks.

Short selling CYCCP is an investing strategy that aims to generate trading profit from Cyclacel Pharmaceuticals as its price is falling. CYCCP shares are trading down $1.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cyclacel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYCCP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYCCP, twice per month. The most recent reporting period available is February, 28 2022.